Co-creation of Pain Science Education for Children Living Beyond Cancer
PANACEA
The Added Value of Pain Science Education for Children Living Beyond Cancer (PANACEA): Co-creation
1 other identifier
observational
24
1 country
1
Brief Summary
A pain science education (PSE) intervention for children (8-12y) living beyond cancer (CBC) will be developed through a co-creational approach with CBC, their parents and pediatric oncology clinicians. The study will be guided by the Intervention Mapping Protocol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 15, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedFirst Posted
Study publicly available on registry
April 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedApril 3, 2024
March 1, 2024
5 months
March 15, 2024
March 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Satisfaction with the co-created intervention
Information about satisfaction of stakeholders (i.e. children living beyond cancer, their parents, and pediatric oncology clinicians) with various aspects of the co-created PSE intervention (e.g., content, complexity, comfort, delivery, and credibility) will be assessed through a small self-developed questionnaire at the end of the last co-creation and concept mapping session. The items of the questionnaire will be based on the ultimately developed intervention and will also include an open-ended question assessing to what extent the developed PSE intervention is what they needed, with the opportunity to suggest alternative treatment content.
at the end of the last co-creation/concept mapping session, approximately 6 months
Secondary Outcomes (3)
Understandability of the co-created intervention
at the end of the last co-creation/concept mapping session, approximately 6 months
Empowerment with regard to the co-created intervention
at the end of the last co-creation/concept mapping session, approximately 6 months
Ownership of the intervention development
at the end of each co-creation/concept mapping session, up to 6 months
Study Arms (3)
Children living beyond cancer
Children between 8-12 years with a history of any cancer diagnosis that are currently in the early survivorship phase (\<2y post-treatment).
Parents of children living beyond cancer
Parents of children (8-12 years) living beyond cancer.
Pediatric oncology clinicians
Clinicians (e.g. physician, nurse, physical therapist, occupational therapist, psychologist, child life specialist) currently employed in pediatric oncology.
Interventions
Participatory approach maximally and directly involving important stakeholders (bottom-up) to co-create a pain science education intervention for children living beyond cancer.
Concept mapping to create a pain science education intervention for children living beyond cancer.
Eligibility Criteria
Children living beyond cancer and their parents will be recruited through patients lists of the participating hospitals (i.e. University Hospital Brussels and University Hospital Ghent), by convenience sampling (e.g. through the research team's networks, calls on social media), and through snowball sampling (i.e. participating dyads search for and encourage other dyads to participate). Oncology clinicians will be recruited from the participating hospitals by email invitation and through the research team's networks. All eligible children, parents, and oncology clinicians will be informed about the study and receive a consent form.
You may qualify if:
- Children living beyond cancer:
- history of (any) cancer diagnosis
- \<2y post-treatment completion (early survivorship phase)
- fluently Dutch speaking and reading
- having access to internet/computer (in order to complete online questionnaires)
- signed informed consent form
- Parents of children living beyond cancer:
- fluently Dutch speaking and reading
- having access to internet/computer (in order to complete online questionnaires)
- signed informed consent form
- Pediatric oncology clinicians:
- currently employed as a physician, nurse, physical therapist, occupational therapist, psychologist, or child life specialist in pediatric oncology
- fluently Dutch speaking and reading
- having access to internet/computer (in order to complete online questionnaires)
You may not qualify if:
- Children living beyond cancer:
- presence of psychiatric disorders or severe intellectual disability
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vrije Universiteit Brussellead
- Universitair Ziekenhuis Brusselcollaborator
- University Ghentcollaborator
- University Hospital, Ghentcollaborator
- University of Calgarycollaborator
Study Sites (1)
Vrije Universiteit Brussel
Jette, Brussels Capital, 1090, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD, Principal Investigator
Study Record Dates
First Submitted
March 15, 2024
First Posted
April 3, 2024
Study Start
April 1, 2024
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
April 3, 2024
Record last verified: 2024-03